Medinol’s patented Flexx² technology is a game-changer in coronary deliverability, especially in tough anatomies. Flexx² is based on a tapered spring tip designed to eliminate tip flare out and buckling while enabling simultaneous flexibility and pushability.
The entire coronary product line of Medinol builds on Flexx² catheters, including the EluNIR drug eluting stent system and the NC Gallant PTCA Catheter.
Flexx² features an innovative spring tip, which radically improves crossability compared to other delivery systems that typically use polymer-based tips. The tapered metallic spring tip is designed to closely track the guidewire and eliminate flare out in bends. It also provides better pushability as the tip is designed to avoid buckling that may get caught in tough lesions or when crossing through deployed stents. In complex anatomies or difficult lesions , the Flexx² spring tip maximizes crossability, where traditional palstic tips get caught or collapse.
The Spring Tip at the Heart of Flexx² Catheter Technology
The only Visible Tip
No Compromise on Flexibility
Flexx² also includes a reinforced hypotube for better hub-to-tip force transfer, enabling to navigate through tortuous anatomy without kinking and a silk-like hydrophilic coating that maximizes tactile feedback. Finally , Flexx² offers the only radio-opaque tip, enabling physicians to visualize actual catheter-tip location during angioplasty – lowering exposure to contrast agents and radiation, and increasing procedure safety and accuracy.
* Test data on file at Medinol